Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug use surveillance of Takecab for Helicobacter pylori eradication
jRCT1080222951
- Sponsor
- Takeda
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of vonoprazan in Helicobacter pylori infection, Peptic ulcer disease (PUD) and gastroduodenal ulcer (2 arms), sponsored by Takeda.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)gastroduodenal ulcer
Beyond the preview
Go deeper on jRCT1080222951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222951.